Volume 14 Supplement 1
Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course
Meeting abstracts
Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.
Society Meeting and 14th Annual Teaching Course: Working together for the patient.
Heidelberg, Germany9-11 October 2014
Page 1 of 2
-
Citation: Cancer Imaging 2014 14(Suppl 1):O1
-
Challenges of cancer imaging in Africa
Citation: Cancer Imaging 2014 14(Suppl 1):O2 -
Global challenges of cancer imaging: perspective from different parts of the world: Asia
Citation: Cancer Imaging 2014 14(Suppl 1):O3 -
Biliary tract neoplasms: detection and staging CT and Ultrasound
Citation: Cancer Imaging 2014 14(Suppl 1):O4 -
MR imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O5 -
Staging of lung cancer CT and PET
Citation: Cancer Imaging 2014 14(Suppl 1):O6 -
Imaging as a guide to tissue sampling
Citation: Cancer Imaging 2014 14(Suppl 1):O7 -
Screening & staging of colorectal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O8 -
MRI for managing intermediate & low risk prostate cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O9 -
PSMA ligands for diagnosis and therapy of prostate cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O10 -
Clinical management of patients with complicated multifocal disease
Citation: Cancer Imaging 2014 14(Suppl 1):O11 -
The do’s and dont’s of liver CT and MR imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O12 -
Prospects and challenges of US and CEUS
Citation: Cancer Imaging 2014 14(Suppl 1):O13 -
Pediatric tumours: pseudotumour or a tumour?
Citation: Cancer Imaging 2014 14(Suppl 1):O14 -
Neuroblastoma and nephroblastoma: an overview and comparison
Citation: Cancer Imaging 2014 14(Suppl 1):O15 -
Pediatric tumours: liver tumours
Citation: Cancer Imaging 2014 14(Suppl 1):O16 -
ICIS workshop on adnexal mass characterization
Citation: Cancer Imaging 2014 14(Suppl 1):O17 -
Ovarian cancer: imaging in treatment selection and planning with FIGO update
Citation: Cancer Imaging 2014 14(Suppl 1):O18 -
Metastasis: imaging shows the way
Citation: Cancer Imaging 2014 14(Suppl 1):O19 -
Locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O20 -
Complications following locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O21 -
Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
Citation: Cancer Imaging 2014 14(Suppl 1):O22 -
FDG-PET in lymphoma
Citation: Cancer Imaging 2014 14(Suppl 1):O23 -
Management of solid and sub-solid lung nodules
Citation: Cancer Imaging 2014 14(Suppl 1):O24 -
Session: Evaluation of lung nodules: role of PET/CT
Citation: Cancer Imaging 2014 14(Suppl 1):O25 -
Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
Citation: Cancer Imaging 2014 14(Suppl 1):O26 -
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Citation: Cancer Imaging 2014 14(Suppl 1):O27 -
Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
Citation: Cancer Imaging 2014 14(Suppl 1):O28 -
Role of molecular imaging in the detection of neuroendocrine tumour
Citation: Cancer Imaging 2014 14(Suppl 1):O29 -
Cancer imaging in the era of precision treatment: present and future
Citation: Cancer Imaging 2014 14(Suppl 1):O30 -
Whole-body MRI and diffusion MRI
Citation: Cancer Imaging 2014 14(Suppl 1):O31 -
Hybrid imaging with PET/CT and PET/MR
Citation: Cancer Imaging 2014 14(Suppl 1):O32 -
Beyond the image : sense and non-sense in imaging biomarkers
Citation: Cancer Imaging 2014 14(Suppl 1):O33 -
PET / MR as tool for ”precision medicine”
Citation: Cancer Imaging 2014 14(Suppl 1):O34 -
Response assessment in daily practice: RECIST and its modifications
Citation: Cancer Imaging 2014 14(Suppl 1):O35 -
Imaging tumour response: beyond RECIST
Citation: Cancer Imaging 2014 14(Suppl 1):O36 -
Abdominal and pelvic complications of molecular targeted therapy
Citation: Cancer Imaging 2014 14(Suppl 1):O37 -
Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features
Citation: Cancer Imaging 2014 14(Suppl 1):O38 -
Comprehensive breast MRI: an update
Citation: Cancer Imaging 2014 14(Suppl 1):O39 -
Contributions of multimodal imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O40 -
Pleura and lung
Citation: Cancer Imaging 2014 14(Suppl 1):O41 -
Incidental findings in the oncology patient: liver
Citation: Cancer Imaging 2014 14(Suppl 1):O42 -
Incidental findings in the oncology patient: pancreas and spleen
Citation: Cancer Imaging 2014 14(Suppl 1):O43 -
Incidental lesion in oncology patients: kidneys
Citation: Cancer Imaging 2014 14(Suppl 1):O44 -
Adrenal masses in oncology patients
Citation: Cancer Imaging 2014 14(Suppl 1):O45 -
Incidental findings in the oncology patient: ovaries
Citation: Cancer Imaging 2014 14(Suppl 1):O46 -
Whole-body DWI in practice
Citation: Cancer Imaging 2014 14(Suppl 1):O47 -
How accurate is 18F-FDG-PET-CT in determining local cartilaginous/bony involvement by head & neck malignancy?
Citation: Cancer Imaging 2014 14(Suppl 1):P1 -
Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan
Citation: Cancer Imaging 2014 14(Suppl 1):P10 -
Impact of three dimensional tomosynthesis on the detection and diagnosis of breast lesions
Citation: Cancer Imaging 2014 14(Suppl 1):P11
Official journal of
-
Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.9 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.636 - SNIP (Source Normalized Impact per Paper)
1.231 - SJR (SCImago Journal Rank)2022 Speed
14 days submission to first editorial decision for all manuscripts (Median)
122 days submission to accept (Median)2022 Usage
798,074 downloads
454 Altmetric mentions